Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schiffman

Showing results (71-80 of 131) with videos related to

Pageof 14
Sort By:
Human Movement Science|June 17, 2019
Effect of walking surface, late-cueing, physiological characteristics of aging, and gait parameters on turn style preference in healthy, older adultsP C Dixon, T Smith, M J D Taylor, et al.
Journal of the National Medical Association|August 13, 2003
Central serous chorioretinopathy in African AmericansUday R Desai, Amir A Alhalel, Thomas J Campen, et al.
Journal of Glaucoma|October 27, 2009
The safety and efficacy of bimatoprost/timolol fixed combination: a 1-year double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertensionRichard A Lewis, Ronald L Gross, Kenneth N Sall, et al.
American Journal of Obstetrics and Gynecology|March 17, 1999
Risk factors for rapid-onset cervical cancerA Hildesheim, O Hadjimichael, P E Schwartz, et al.
The British Journal of Ophthalmology|June 8, 2013
Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trialDouglas G Day, Thomas R Walters, Gail F Schwartz, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 13, 2006
Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trialMark B Sherwood, E Randy Craven, Connie Chou, et al.
Journal of Biomechanics|September 2, 2021
Muscle co-contractions are greater in older adults during walking at self-selected speeds over uneven compared to even surfacesMatthew M DaSilva, Vishnu D Chandran, Philippe C Dixon, et al.
Proceedings. Symposium on Computer Applications in Medical Care|January 1, 1991
Design considerations of CareWindows, a Windows 3.0-based graphical front end to a Medical Information Management System using a pass-through-requester architectureR E Ward, T Purves, M Feldman, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 1, 2011
Ocular penetration and anti-inflammatory activity of ketorolac 0.45% and bromfenac 0.09% against lipopolysaccharide-induced inflammationL David Waterbury, Danielle Galindo, Linda Villanueva, et al.
Current Medical Research and Opinion|March 31, 2012
Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison studyL Jay Katz, Steven H Rauchman, Andrew J Cottingham, et al.
Pageof 14

Showing results (71-80 of 131) with videos related to

Sort By:
Pageof 14
Human Movement Science|June 17, 2019
Effect of walking surface, late-cueing, physiological characteristics of aging, and gait parameters on turn style preference in healthy, older adultsP C Dixon, T Smith, M J D Taylor, et al.
Journal of the National Medical Association|August 13, 2003
Central serous chorioretinopathy in African AmericansUday R Desai, Amir A Alhalel, Thomas J Campen, et al.
Journal of Glaucoma|October 27, 2009
The safety and efficacy of bimatoprost/timolol fixed combination: a 1-year double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertensionRichard A Lewis, Ronald L Gross, Kenneth N Sall, et al.
American Journal of Obstetrics and Gynecology|March 17, 1999
Risk factors for rapid-onset cervical cancerA Hildesheim, O Hadjimichael, P E Schwartz, et al.
The British Journal of Ophthalmology|June 8, 2013
Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trialDouglas G Day, Thomas R Walters, Gail F Schwartz, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 13, 2006
Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trialMark B Sherwood, E Randy Craven, Connie Chou, et al.
Journal of Biomechanics|September 2, 2021
Muscle co-contractions are greater in older adults during walking at self-selected speeds over uneven compared to even surfacesMatthew M DaSilva, Vishnu D Chandran, Philippe C Dixon, et al.
Proceedings. Symposium on Computer Applications in Medical Care|January 1, 1991
Design considerations of CareWindows, a Windows 3.0-based graphical front end to a Medical Information Management System using a pass-through-requester architectureR E Ward, T Purves, M Feldman, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 1, 2011
Ocular penetration and anti-inflammatory activity of ketorolac 0.45% and bromfenac 0.09% against lipopolysaccharide-induced inflammationL David Waterbury, Danielle Galindo, Linda Villanueva, et al.
Current Medical Research and Opinion|March 31, 2012
Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison studyL Jay Katz, Steven H Rauchman, Andrew J Cottingham, et al.
Pageof 14